Skip to content

Pelvic Floor Muscle Training on the Quality of Life in Women With Urinary Incontinence

The Effect of Pelvic Floor Muscle Training on the Quality of Life and Functionality in Women With Urinary Incontinence: a Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03514147
Enrollment
56
Registered
2018-05-02
Start date
2015-10-31
Completion date
2017-07-31
Last updated
2018-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Quality of Life, Urinary Incontinence

Keywords

Women, Pelvic Floor Muscles

Brief summary

Aim: To assess the influence of pelvic floor muscles group training in the quality of life and functionality of these muscles in women with UI. Study design: This is a randomized controlled trial.

Detailed description

Search location: Urogynecology Ambulatory Care of Porto Alegre Clinical Hospital (HCPA) Patients or participants: Women will be included in aged 35-70 years who have had sexual intercourse in the last 12 months and who are able to understand the instruments, besides signing an informed consent form. Women will be excluded with latex allergy, who have made pelvic radiotherapy, or be undergoing chemotherapy, puerperal a year, or who use antidepressants and / or anxiolytics. Intervention and measures: The evaluation consists of a medical history form, which will include personal data; the assessment of the MAP function is performed by the pressure biofeedback; for assessment of quality of life will use the questionnaire ICQI-SF and sexual function the PISQ-12 before and after Pelvic Floor Muscle Training. Expected results: To estimate effectiveness of Pelvic Floor Muscle Training in the quality of life and functionality of these muscles in women with urinary incontinence.

Interventions

OTHERExperimental

1. Profile of participants: an anamnesis file was used to collect personal data; 2. To evaluate the quality of life: To evaluate the quality of life, using International Consultation on Incontinence Questionnaire (ICIQ-Short form) in women with urinary incontinence in baseline and after 12 weeks of intervention; 3. To evaluate the pelvic floor muscle functionality: To evaluate the pelvic floor muscle functionality, using PERFECT Scale and Pressure Biofeedback in baseline and after 12 weeks of intervention;

OTHERControl

1. Profile of participants: an anamnesis file was used to collect personal data; 2. To evaluate the quality of life: To evaluate the quality of life, using International Consultation on Incontinence Questionnaire (ICIQ-Short form) in women with urinary incontinence in baseline and after 12 weeks of intervention; 3. To evaluate the pelvic floor muscle functionality: To evaluate the pelvic floor muscle functionality, using PERFECT Scale and Pressure Biofeedback in baseline and after 12 weeks of intervention;

Sponsors

Hospital de Clinicas de Porto Alegre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Female; * Have urinary incontinence; * Age between 35 and 70 years; * Have sexual intercourse in the last 6 months; * Participants should understand the instruments used in the research; * Accept to participate in the study and sign the Term of Free and Informed Consent.

Exclusion criteria

* Latex allergy; * Have performed or are undergoing pelvic radiotherapy; * Be performing chemotherapy treatment; * Women who delivered during the last 12 months; * Have participated in individual or group MAP training in the last 6 months; * Have contraction of the pelvic floor muscles grade zero (0).

Design outcomes

Primary

MeasureTime frameDescription
Quality of life in women with urinary incontinence12 weeksInternational Consultation on Incontinence Questionnaire - Short Form (ICIQ-SF) - scored between 0 and 21.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026